Português
logo

News

FAPESP and GlaxoSmithKline announce results of call for proposals Versão em português

FAPESP and GlaxoSmithKline announce results of call for proposals

FAPESP and GlaxoSmithKline Brasil (GSK) announce the results of a Call for Proposals issued on May 17, 2012 under the cooperation agreement between the institutions.

The Call for Proposals was open for research proposals in the following topics: “Metabolic Diseases”, “Tropical and Neglected Diseases”, “Infectious Diseases”, “Respiratory Diseases”, “Inflammation and Immunology” and “Biopharmaceuticals and Vaccines”.

The total amount available for the Call for Proposals is US$ 600,000.00, with a maximum of US$ 200.000 per project.

Selected proposals:

Researchers

Title

Acary Souza Bulle Oliveira 
Esc. Paulista de Medicina - Unifesp
Área: Speech Therapy
FAPESP#: 2012/50370-6 
 


Evaluation of dysphagia as prognostic model in compromise of orofaringolaringeais structures and functions in patients with motor neuron disease

 

Jean Leandro dos Santos
Fac. Ciências Farmacêuticas Araraquara - Unesp Area: Pharmacy
FAPESP#: 2012/50359-2
 


Design, synthesis and pharmacological evaluation of new hybrid drugs useful to treat hematological disorders

 


Luis Carlos de Souza Ferreira
Inst. Ciências Biomédicas – USP
Area: Microbiology
FAPESP#: 2012/50362-3
 


Vaccines for dengue fever control delivered via intradermal and transcutaneous routes

 
The Call for Proposals is available at: www.fapesp.br/6863.



 

URL: https://fapesp.br./7184/fapesp-and-glaxosmithkline-announce-results-of-call-for-proposals
Page updated on 09/10/2012 - Published on 09/06/2012